WMFE is Central Florida's primary provider of NPR programming on 90.7 FM and Classical Music on 90.7 HD2. Part of the community since 1965, WMFE focuses on providing quality national and local news and programming. We inspire and empower all Central Floridians to discover, grow and engage within and beyond their world.
Support for 90.7 WMFE is provided by

Immunotherapy Might Improve Survival Outcomes in Late-Stage Lung Cancer Patients


Play Audio
Immunotherapy could be the cure for late-stage lung cancer. Photo: Flickr Creative Commons

Immunotherapy could be the cure for late-stage lung cancer. Photo: Flickr Creative Commons

Stay up to date on coronavirus coverage: Listen to WMFE on your radio, the WMFE mobile app or your smart speaker — say “Alexa, play NPR” or “WMFE” and you’ll be connected.

A study in the New England Journal of Medicine found that immunotherapy could improve survival outcomes in patients with an aggressive form of lung cancer. Florida Hospital Cancer Institute’s Dr. Mark Socinski says the drug should be a first-line treatment for patients.

“For patients diagnosed with lung cancer, make sure that you get the proper molecular staging done. Make sure the patient understands that immunotherapy is an option. And there are certain biomarkers that we use to make sure that immunotherapy is the best way to go.”

Socinski says most doctors think of the disease as treatable, but not curable, but the drug could change that. The American Cancer Society estimates that only about ten percent of people with the late stage of the disease survive for more than 5 years after their diagnosis.

If you’d like to listen to the full story, please click on the clip above.


Get The 90.7 WMFE Newsletter

Your trusted news source for the latest Central Florida COVID-19 news, updates on special programs and more. Support our extended coverage.

GET THE LATEST

WMFE Journalistic Ethics Code | Public Media Code of Integrity

Danielle Prieur

About Danielle Prieur

Reporter

TOP